latest update:
[TrialBase DB]

trial summary · NCT06487481

Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma

A Phase I Dose-escalation Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma

Trial record from the TrialBase DB dataset, status RECRUITING, condition Adrenocortical Carcinoma (ACC), sponsored by National Cancer Institute (NCI). Facts below are exported values from the current release, not inferred or edited prose.

registry NCT06487481phase PHASE1enrollment 32start 2026-11-04

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

Background: Adrenocortical carcinoma (ACC) is a rare cancer of the adrenal glands. ACC often returns after tumors are removed with surgery. Less than 35% of people with ACC survive 5 years after diagnosis. Objective: To test a new type of external beam RT before surgery in people with ACC. Eligibility: People aged 18 years and older with ACC that came back after treatment but may be safely removed with surgery. Design: Participants will be screened. They will have a physical exam with blood and urine tests. They will have tests of their heart function. They will have imaging scans. A small sample of tumor tissue may be collected if one is not available. They will undergo laparoscopy: Small incisions will be made in the abdomen so that a thin tube with a light and camera can be inserted to view the organs. RT comes from a machine that aims radiation at tumors. Participants will receive preoperative RT in daily fractions over approximately 2-3 weeks, followed by a planned surgical resection about 4 weeks after the completion of RT. Visits will last 30 to 60 minutes. Participants will undergo surgery to remove their tumors about 4 weeks after they finish RT. They will stay in the hospital 1 to 3 weeks after surgery. Participants will have follow-up visits for 10 years after surgery.

Source record: https://clinicaltrials.gov/study/NCT06487481

Facts

registry idNCT06487481
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasePHASE1
study typeINTERVENTIONAL
lead conditionAdrenocortical Carcinoma (ACC)
sponsorNational Cancer Institute (NCI)
sponsor classNIH
enrollment32
start date2026-11-04
primary completion2030-12-01
completion2040-12-01
results postednot reported

Conditions

  • Adrenocortical Carcinoma (ACC)
  • Recurrent Adrenocortical Carcinoma (ACC)
  • Recurrent Abdominal Adrenocortical Carcinoma (ACC)
  • Carcinoma, Adrenocortical
  • Carcinoma, Adrenal Cortical

Interventions

  • Surgical resection
  • Preoperative RT

Countries

  • United States

Intervention types: PROCEDURE, RADIATION

Work with this record